Skip to main content

Table 2 Suppression of tumor growth by DHMEQ in combination with paclitaxel in T24PR mouse xenograft model

From: Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

 

tumor volume (mm3)

apoptotic index (%)

proliferation index (%)

control

486.3 ± 25.3

1.5 ± 0.3

83.7 ± 3.3

paclitaxel

403.8 ± 36.3*

3.9 ± 0.9*

69.1 ± 4.8*

palitaxel + DHMEQ

160.8 ± 20.3*, **

10.0 ± 0.8*, **

34.3 ± 3.6*, **

  1. *P < 0.05 compared with control; **P < 0.05 compared with paclitaxel.